ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
cibinqo
pfizer europe ma eeig - abrocitinib - dermatitis, atópísk - aðrar húðsjúkdómar - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
solifenacin alvogen 5 mg filmuhúðuð tafla (solifenacin portfarma) filmuhúðuð tafla 5 mg
alvogen ehf. - solifenacinum súkkínat - filmuhúðuð tafla - 5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 8 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 16 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 16 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 16 mg
teva b.v.* - candesartanum cílexetíl - tafla - 16 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 8 mg
teva b.v.* - candesartanum cílexetíl - tafla - 8 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress comp tafla 16 mg/12,5 mg
teva b.v.* - candesartanum cílexetíl; hydrochlorothiazide - tafla - 16 mg/12,5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 32 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 32 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
solifenacin alvogen 10 mg filmuhúðuð tafla (solifenacin portfarma) filmuhúðuð tafla 10 mg
alvogen ehf. - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.